James Ziai

6PUBLICATIONS
61CO-AUTHORS
Molecular targetsGenomics and transcriptomicsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 06, 2026
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity.

|Feb 25, 2026
VSIG4 Restricts Hepatocellular Carcinoma Control by Suppressing Tumor-Specific CD8+ T-cell Immunity in the Tumor Microenvironment.

Jinglong Guo, Siddheshvar Bhela, Monica Sharma

|Aug 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis.

Xiao Li, Ximo Pechuan-Jorge, Tyler Risom

|Mar 16, 2021
Clinical and research applications of multiplexed immunohistochemistry and in situ hybridization.

Lisa M McGinnis, Veronica Ibarra-Lopez, Sandra Rost

|Dec 21, 2018
New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue.

Jérémie Decalf, Matthew L Albert, James Ziai

|Jan 11, 2018
CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.

James Ziai, Houston N Gilbert, Oded Foreman

Pageof 1

Frequent Collaborators

2 joint publications

Conrad Foo

2 joint publications

Caleb Chan

2 joint publications

Sören Müller

2 joint publications

Rajiv Jesudason